Blennow, Kaj
University of Science and Technology of China · Sorbonne Université · Institut des Sciences Moléculaires · Pitié-Salpêtrière Hospital · UK Dementia Research Institute · Institut du Cerveau · UCL Queen Square Institute of Neurology · University College London
317 papers on CoChatORCID 0000-0002-1890-4193
Most cited papers
- Verified
Cystatin C Levels are Positively Correlated with both Aβ42 and Tau Levels in Cerebrospinal Fluid in Persons with Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Controls
Sundelöf, J., Sundström, J., Hansson, O., Eriksdotter-Jönhagen, M., Giedraitis, V., Larsson, A., Degerman-Gunnarsson, M., Ingelsson, M., Minthon, L., Blennow, K., et al. (2010) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 32
- Verified
TREM2 expression in the brain and biological fluids in prion diseases
Diaz-Lucena, D., Kruse, N., Thüne, K., Schmitz, M., Villar-Piqué, A., da Cunha, J. E. G., Hermann, P., López-Pérez, Ó., Andrés-Benito, P., Ladogana, A., et al. (2021) · Acta Neuropathologica
Prion Diseases and Protein MisfoldingNeuroinflammation and Neurodegeneration Mechanisms
Cited by 32
- Verified
Increased frequency of a new polymorphism in the cell division cycle 2 (cdc2) gene in patients with Alzheimer's disease and frontotemporal dementia
Johansson, A., Hampel, H., Faltraco, F., Buerger, K., Minthon, L., Bogdanovic, N., Sjögren, M., Zetterberg, H., Forsell, L., Lilius, L., et al. (2003) · Neuroscience Letters
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 31
- Verified
Second-generation Elecsys cerebrospinal fluid immunoassays aid diagnosis of early Alzheimer’s disease
Blennow, K., Stomrud, E., Zetterberg, H., Borlinghaus, N., Corradini, V., Manuilova, E., Müller-Hübner, L., Quevenco, F.-C., Rutz, S., & Hansson, O. (2023) · Clinical Chemistry and Laboratory Medicine (CCLM)
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 30
- Verified
Common variants in Alzheimer’s disease: Novel association of six genetic variants with AD and risk stratification by polygenic risk scores
de Rojas, I., Moreno-Grau, S., Tesi, N., Grenier-Boley, B., Andrade, V., Jansen, I., Pedersen, N. L., Stringa, N., Zettergren, A., Hernández, I., et al. (2019) · medRxiv
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 28
- Verified
Comparison of CSF and plasma NfL and pNfH for Alzheimer's disease diagnosis: a memory clinic study
Vrillon, A., Ashton, N. J., Karikari, T. K., Götze, K., Cognat, E., Dumurgier, J., Lilamand, M., Zetterberg, H., Blennow, K., & Paquet, C. (2024) · Journal of Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 28
- Verified
Altered T-cell reactivity in the early stages of Alzheimer's disease
Rickenbach, C., Mallone, A., Häusle, L., Frei, L., Seiter, S., Sparano, C., Kirabali, T., Blennow, K., Zetterberg, H., Ferretti, M. T., et al. (2025) · Brain
Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms
Cited by 27
- Verified
CSF Biomarkers of Alzheimer Disease in Patients With Concomitant α-Synuclein Pathology
Cousins, K. A. Q., Arezoumandan, S., Shellikeri, S., Ohm, D., Shaw, L. M., Grossman, M., Wolk, D., McMillan, C. T., Chen-Plotkin, A., Lee, E., et al. (2022) · Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 25
- Verified
Semagacestat's fall: where next for AD therapies?
Blennow, K., Zetterberg, H., Haass, C., & Finucane, T. (2013) · Nature Medicine
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 24
- Verified
Genetic Mapping of APP and Amyloid-β Biology Modulation by Trisomy 21
Mumford, P., Tosh, J., Anderle, S., Gkanatsiou Wikberg, E., Lau, G., Noy, S., Cleverley, K., Saito, T., Saido, T. C., Yu, E., et al. (2022) · The Journal of Neuroscience
Alzheimer's disease research and treatmentsDown syndrome and intellectual disability research
Cited by 22
- Verified
Low cerebrospinal fluid sulfatide predicts progression of white matter lesions: The LADIS study
Jonsson, M., Zetterberg, H., Rolstad, S., Edman, A., Gouw, A. A., Bjerke, M., Lind, K., Blennow, K., Pantoni, L., Inzitari, D., et al. (2012) · Dementia and Geriatric Cognitive Disorders
Cerebrovascular and genetic disordersDementia and Cognitive Impairment Research
Cited by 22
- Verified
Reduced cerebrospinal fluid concentration of interleukin-12/23 subunit p40 in patients with cognitive impairment
Johansson, P., Almqvist, E. G., Wallin, A., Johansson, J.-O., Andreasson, U., Blennow, K., Zetterberg, H., & Svensson, J. (2017) · PLOS ONE
Neuroinflammation and Neurodegeneration MechanismsAlzheimer's disease research and treatments
Cited by 20
- Verified
Evaluation of two plasma‐based proteotyping assays against APOE ε4 genotyping in a memory clinic setting: The Gothenburg H70 Clinical Studies
Dittrich, A., Blennow, K., Tan, K., Benedet, A. L., Skoog, I., Höglund, K., Ashton, N. J., Zetterberg, H., & Kern, S. (2025) · Alzheimer's & Dementia
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 18
- Verified · note
The impact of social networks and APOE ε4 on dementia among older adults: tests of possible interactions
Wu, J., Hasselgren, C., Zettergren, A., Zetterberg, H., Blennow, K., Skoog, I., & Halleröd, B. (2020) · Aging & Mental Health
Dementia and Cognitive Impairment ResearchHealth disparities and outcomes
Cited by 18
- Verified
Alzheimer’s Disease-Associated Cerebrospinal Fluid (CSF) Biomarkers do not Correlate with CSF Volumes or CSF Production Rate
Edsbagge, M., Andreasson, U., Ambarki, K., Wikkelsø, C., Eklund, A., Blennow, K., Zetterberg, H., & Tullberg, M. (2017) · Journal of Alzheimer's Disease
Cerebrospinal fluid and hydrocephalusAlzheimer's disease research and treatments
Cited by 17
- Verified
Cerebrospinal Fluid 7-Ketocholesterol Level is Associated with Amyloid-β42 and White Matter Microstructure in Cognitively Healthy Adults
Iriondo, A., García-Sebastian, M., Arrospide, A., Arriba, M., Aurtenetxe, S., Barandiaran, M., Clerigue, M., Ecay-Torres, M., Estanga, A., Gabilondo, A., et al. (2020) · Journal of Alzheimer's Disease
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 16
- Verified
Differences and similarities between familial and sporadic frontotemporal dementia: an Italian single-center cohort study
Benussi, A., Libri, I., Premi, E., Alberici, A., Cantoni, V., Gadola, Y., Rivolta, J., Pengo, M., Gazzina, S., Calhoun, V. D., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions
Dementia and Cognitive Impairment ResearchAmyotrophic Lateral Sclerosis Research
Cited by 14
- Verified
Improved Cerebrospinal Fluid-Based Discrimination between Alzheimer’s Disease Patients and Controls after Correction for Ventricular Volumes
van Waalwijk van Doorn, L. J. C., Gispert, J. D., Kuiperij, H. B., Claassen, J. A. H. R., Arighi, A., Baldeiras, I., Blennow, K., Bozzali, M., Castelo-Branco, M., Cavedo, E., et al. (2017) · Journal of Alzheimer’s Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 13
- Verified
Plasma Phosphorylated Tau 217 Cutoffs for Amyloid Pathology and Kidney Function, Body Mass Index, and Anemia
Yun, J., Lee, J., Shin, D., Lee, E. H., Kim, J. P., Ham, H., Gu, Y., Chun, M. Y., Kang, S. H., Kim, H. J., et al. (2026) · JAMA Neurology
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 13
- VerifiedRetracted
Lower CSF interleukin-6 predicts future depression in a population-based sample of older women followed for 17 years
Kern, S., Skoog, I., Börjesson-Hanson, A., Blennow, K., Zetterberg, H., Östling, S., Kern, J., Gudmundsson, P., Marlow, T., Rosengren, L., et al. (2013) · Brain, Behavior, and Immunity
Tryptophan and brain disordersStress Responses and Cortisol
Cited by 13
- Verified
Evaluation of in vivo staging of amyloid deposition in cognitively unimpaired elderly aged 78–94
Michalowska, M. M., Herholz, K., Hinz, R., Amadi, C., McInnes, L., Anton-Rodriguez, J. M., Karikari, T. K., Blennow, K., Zetterberg, H., Ashton, N. J., et al. (2022) · Molecular Psychiatry
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 11
- Verified
Blood pressure and Alzheimer’s disease biomarkers in cognitively unimpaired adults: a multicenter study
Osset-Malla, M., Martínez-Velasco, A., Sánchez-Benavides, G., Buongiorno, M., de la Sierra, A., Shekari, M., Minguillon, C., Kollmorgen, G., Quijano-Rubio, C., Zetterberg, H., et al. (2025) · The Journal of Prevention of Alzheimer's Disease
Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments
Cited by 8
- Verified
Association of brain network dynamics with plasma biomarkers in subjective memory complainers
Chiesa, P. A., Houot, M., Vergallo, A., Cavedo, E., Lista, S., Potier, M. C., Zetterberg, H., Blennow, K., Vanmechelen, E., De Vos, A., et al. (2020) · Neurobiology of Aging
Functional Brain Connectivity StudiesDementia and Cognitive Impairment Research
Cited by 7
- Verified
Consensus meta-analysis of genome-wide association studies for Alzheimer’s disease and related dementias
EADB, Bellenguez, C., Castillo Morales, A., Amin, N., van der Lee, S. J., Muntaner, M., Parveen, K., Küçükali, F., Grenier-Boley, B., Heikkinen, S., et al. (2026) · Nature Genetics
Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research
Cited by 7
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free